Life Sciences
Life Sciences Tax Update: R&D and OBBB Changes
The tax landscape continues to evolve, creating both opportunities and planning considerations for life sciences companies at every stage of growth.
Overview
Rich brings more than 35 years of tax experience to privately held and publicly traded companies across the United States and internationally. He advises growth-oriented businesses navigating complex tax environments, offering practical guidance grounded in industry knowledge spanning software, biotechnology, medical device, life sciences, manufacturing, retail, professional services, and publishing.
Business leaders engage Rich to connect tax planning with broader operational and financial goals. Working alongside executive and finance teams, he identifies opportunities to streamline operations, manage tax exposure, and maintain regulatory compliance. His recommendations reflect each organization’s financial profile and long-term strategy, whether evaluating entity structure, assessing the timing of income and deductions, or identifying credits and incentives that strengthen cash flow and support reinvestment.
He also advises European-based companies expanding into the U.S. market. From structuring U.S. operations to addressing tax residency and multi-state compliance, Rich provides clear direction within a complex federal and international framework. His work helps global companies establish a stable foundation for growth in the United States.
As a leader in AAFCPAs’ Business Transaction Advisory practice, Rich supports clients through buy-side and sell-side transactions. A Certified Merger & Acquisition Advisor® (CM&AA), he guides business owners and shareholders through each phase of the M&A process including due diligence, financial modeling, valuation, deal structuring, negotiation, and closing. He helps clients prepare for ownership transitions, address tax considerations early, and structure transactions to support long-term financial goals. Rich is an AM&AA New England Chapter Executive Committee member.
Education
- Bentley University – Master of Science in Taxation (MST)
- Boston University – Bachelor of Science, Accounting
Service
- Alliance of Merger & Acquisition Advisors (AM&AA)
- American Institute of Certified Public Accountants
- Association for Corporate Growth (ACG)
- Exit Planning Exchange (XPX)
- New England Society of Certified Public Accountants (NECPAs)
Publications
- MedCity News (June 18, 2026): What Life Sciences Companies Get Wrong When Building Cross-Border R&D Structures
Industry Expertise
Articles by RICHARD
Contributed Insights.
Stay up-to-date on trending topics, fresh perspectives, in-depth analysis, and regulatory alerts that affect your business.
Transaction Advisory
The Tax Decisions Behind a Successful Business Sale
A business sale may be defined by a single purchase price, but the structure behind the transaction can influence taxes, negotiations, and the amount a...
Life Sciences
Essential Financial Strategies for Life Sciences Companies Seeking Strategic Exit
Interest is rising in life‑science pipelines, and companies that succeed combine strong science with disciplined financial and operational foundations.
